Ebolavirus vaccines for humans and apes

Hugues Fausther-Bovendo, Sabue Mulangu, Nancy J. Sullivan

Research output: Contribution to journalReview articlepeer-review

Abstract

Because of high case fatality proportions, person-to-person transmission, and potential use in bioterrorism, the development of a vaccine against ebolavirus remains a top priority. Although no licensed vaccine or treatment against ebolavirus is currently available, progress in preclinical testing of countermeasures has been made. Here, we will review ebolavirus vaccine candidates and considerations for their use in humans and wild apes.

Original languageEnglish (US)
Pages (from-to)324-329
Number of pages6
JournalCurrent Opinion in Virology
Volume2
Issue number3
DOIs
StatePublished - Jun 2012
Externally publishedYes

ASJC Scopus subject areas

  • Virology

Fingerprint

Dive into the research topics of 'Ebolavirus vaccines for humans and apes'. Together they form a unique fingerprint.

Cite this